Johnson & Johnson receives permanent billing code for bladder cancer treatment

Go back to Johnson & Johnson receives permanent billing code for bladder cancer treatment
Johnson & Johnson (NYSE: JNJ) Delayed: 228.17 +4.93 (2.21%)
Previous Close $223.24    52 Week High $126.07 
Open $227.09    52 Week Low $94.28 
Day High $228.67    P/E 47.44 
Day Low $225.90    EPS $4.81 
Volume 7,274,160